Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Development of a Prognostic Model That Predicts Survival After Pancreaticoduodenectomy for Ampullary Cancer.

Feretis M, Wang T, Iype S, Duckworth A, Brais R, Basu B, Jamieson NV, Huguet E, Balakrishnan A, Jah A, Praseedom RK, Harper SJ, Liau SS.

Pancreas. 2017 Nov/Dec;46(10):1314-1321. doi: 10.1097/MPA.0000000000000929.

2.

Prognostic impact of immunohistochemical expression of CK7 and CK20 in curatively resected ampulla of Vater cancer.

Yun SP, Seo HI.

BMC Gastroenterol. 2015 Nov 24;15:165. doi: 10.1186/s12876-015-0396-x.

3.

Management of ampullary neoplasms: A tailored approach between endoscopy and surgery.

Panzeri F, Crippa S, Castelli P, Aleotti F, Pucci A, Partelli S, Zamboni G, Falconi M.

World J Gastroenterol. 2015 Jul 14;21(26):7970-87. doi: 10.3748/wjg.v21.i26.7970. Review.

4.

Impact of Standardized Allergen-Removed Rhus verniciflua Stokes Extract on Advanced Adenocarcinoma of the Ampulla of Vater: A Case Series.

Choi W, An S, Kwon E, Eo W, Lee S.

Evid Based Complement Alternat Med. 2013;2013:203168. doi: 10.1155/2013/203168. Epub 2013 Apr 22.

5.

Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas.

Ohike N, Coban I, Kim GE, Basturk O, Tajiri T, Krasinskas A, Bandyopadhyay S, Morohoshi T, Shimada Y, Kooby DA, Staley CA, Goodman M, Adsay NV.

Am J Surg Pathol. 2010 Oct;34(10):1417-24. doi: 10.1097/PAS.0b013e3181f0b05a. Erratum in: Am J Surg Pathol. 2010 Dec;34(12):1892. Volkan Adsay, Nazmi [corrected to Adsay, N. Volkan].

6.

COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables.

Perrone G, Santini D, Verzì A, Vincenzi B, Borzomati D, Vecchio F, Coppola R, Antinori A, Magistrelli P, Tonini G, Rabitti C.

J Clin Pathol. 2006 May;59(5):492-6. Epub 2006 Feb 17.

7.

KL-6 mucin expression in carcinoma of the ampulla of Vater: association with cancer progression.

Tang W, Inagaki Y, Kokudo N, Guo Q, Seyama Y, Nakata M, Imamura H, Sano K, Sugawara Y, Makuuchi M.

World J Gastroenterol. 2005 Sep 21;11(35):5450-4.

8.

Our local experience with the surgical treatment of ampullary cancer.

Botsios D, Zacharakis E, Lambrou I, Tsalis K, Christoforidis E, Kalfadis S, Zacharakis E, Betsis D, Dadoukis I.

Int Semin Surg Oncol. 2005 Aug 30;2:16.

9.

Clinicopathologic analysis of early ampullary cancers with a focus on the feasibility of ampullectomy.

Yoon YS, Kim SW, Park SJ, Lee HS, Jang JY, Choi MG, Kim WH, Lee KU, Park YH.

Ann Surg. 2005 Jul;242(1):92-100.

10.

Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma.

Kato M, Kitayama J, Kazama S, Nagawa H.

Breast Cancer Res. 2003;5(5):R144-50. Epub 2003 Jul 17.

11.

Cancer of the ampulla of Vater: chromosome 17p allelic loss is associated with poor prognosis.

Scarpa A, Di Pace C, Talamini G, Falconi M, Lemoine NR, Iacono C, Achille A, Baron A, Zamboni G.

Gut. 2000 Jun;46(6):842-8.

12.

Factors predictive of survival in ampullary carcinoma.

Howe JR, Klimstra DS, Moccia RD, Conlon KC, Brennan MF.

Ann Surg. 1998 Jul;228(1):87-94.

13.

Adenocarcinoma of the ampulla of Vater. A 28-year experience.

Talamini MA, Moesinger RC, Pitt HA, Sohn TA, Hruban RH, Lillemoe KD, Yeo CJ, Cameron JL.

Ann Surg. 1997 May;225(5):590-9; discussion 599-600.

Supplemental Content

Support Center